(Updated - September 24, 2026 5:37 AM EDT)

Goldman Sachs analyst Andrea Newkirk assumes coverage on Madrigal Pharmaceuticals (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE